News | November 28, 2024
Granules' net zero commitment approved by SBTi
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
New Board of Directors and management team at Suven Pharma also appointed
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
The audit is a pre-approval inspection for three products filed from the facility
Granules now have a total of 53 ANDA approvals from USFDA
He was previously associated with renowned companies such as Granules India Ltd, Dr. Reddy’s Laboratories ltd & Aptar Group
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
Subscribe To Our Newsletter & Stay Updated
